Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Thymidylate synthase inhibitor design

Fig. 8. Thymidylate synthase inhibitors designed to fit into the A/, AJ -methylenetetrahydrofolate binding site. The best inhibitors from each class are the classical antifolate TS inhibitor (31), the naphthostyril-based lead compound (32), and the tetrahydroquinoline-based lead compound (33), iC values (in nAI)... Fig. 8. Thymidylate synthase inhibitors designed to fit into the A/, AJ -methylenetetrahydrofolate binding site. The best inhibitors from each class are the classical antifolate TS inhibitor (31), the naphthostyril-based lead compound (32), and the tetrahydroquinoline-based lead compound (33), iC values (in nAI)...
Fig. 7. Thymidylate synthase inhibitors designed to bind in the cofactor-binding site using crystal structure of coli enzyme complexed with 5-fluoro-2 -deoxyuridylate (35). Fig. 7. Thymidylate synthase inhibitors designed to bind in the cofactor-binding site using crystal structure of coli enzyme complexed with 5-fluoro-2 -deoxyuridylate (35).
Fig. 26.17 Structure-based design of thymidylate synthase inhibitors, (a) The coenzyme 5,10-methylenete-trahydrofotate. (b) The classical antifolate CB3717. (c) Interactions of the pteridine moiety of CB3717 with active site residues Asp169 and Ala263 and with wat430, a bound water molecule. For explanation, see text. (Adapted, with permission, from Reich, S.H. and Webber, S.E. (1993) Perspect. Drug Dis. Des. 1 371-390. 1993 Escom Science Publishers B.V.)... Fig. 26.17 Structure-based design of thymidylate synthase inhibitors, (a) The coenzyme 5,10-methylenete-trahydrofotate. (b) The classical antifolate CB3717. (c) Interactions of the pteridine moiety of CB3717 with active site residues Asp169 and Ala263 and with wat430, a bound water molecule. For explanation, see text. (Adapted, with permission, from Reich, S.H. and Webber, S.E. (1993) Perspect. Drug Dis. Des. 1 371-390. 1993 Escom Science Publishers B.V.)...
Fig. 26.18 Structure-based design of thymidylate synthase inhibitors, (a) Drug lead 2-methyl-2-desamino-/ / °-propargyl-5,8-dideazafolic acid, (b) Derivative lacking the CO-L-glutamate mpiety. (c) Designed diphenylsulfone derivative, (d) AG85, a designed A7-sulfonylindole derivative selected for clinical evaluation. Fig. 26.18 Structure-based design of thymidylate synthase inhibitors, (a) Drug lead 2-methyl-2-desamino-/ / °-propargyl-5,8-dideazafolic acid, (b) Derivative lacking the CO-L-glutamate mpiety. (c) Designed diphenylsulfone derivative, (d) AG85, a designed A7-sulfonylindole derivative selected for clinical evaluation.
Fig, 26.19 Structure-based design of thymidylate synthase inhibitors de novo design of a novel lead structure. See text for explanation. [Pg.436]

Figure 12 Design paradigm used in the structure-based discovery of thymidylate synthase inhibitors. ... Figure 12 Design paradigm used in the structure-based discovery of thymidylate synthase inhibitors. ...
The 6-methylacetylamino-l,2,3,4-tetrahydroquinoline, after nitration and separation of isomers, following reduction and deprotection, gave the 7-amino-6-methylamino derivative, which cyclized with cyanogen bromide. Alkylation of the cyclization products afforded inhibitors of thymidylate synthase, 5-substituted 2-amino-l//-l-methyl-5,6,7,8-tetrahydroimidazo[4,5-g]quinolines 136, designed for use in iterative protein crystal analysis (Scheme 42) (92JMC847). [Pg.246]

Fig. 1.4 The increase in thymidylate synthase inhibition activity obtained from an initial hit identified as a disulphide-bound enzyme adduct and optimised to a reversible potent 330nM inhibitor using crystal structure-guided design. Fig. 1.4 The increase in thymidylate synthase inhibition activity obtained from an initial hit identified as a disulphide-bound enzyme adduct and optimised to a reversible potent 330nM inhibitor using crystal structure-guided design.
R. W. Ward, J. White, E. W. Moomaw, C. A. Bartlett, and C. A. Morse, Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase, J. Med. Chem. 39 904 (1996). [Pg.342]

Varney MD, Marzoni GP, Palmer CL, Deal JG, Webber S, Welsh KM, Bacquet RJ, Bartlett CA, Morse CA, Booth CLJ, Herrmann SM, Howland EF, Ward RW, White J. Crystal-structure-based design of Benz[cd]indole-containing inhibitors of thymidylate synthase. JMed Chem 1992 35 663-676. [Pg.537]

Human thymidylate synthase (TS) A 5-substituted lH-benzo cd indol-2-one scaffold was designed de novo based on a key interaction pattern identified from previous X-ray analyses, and on a GRID analysis of the TS crystal structure. X-ray analysis of the complex with a newly designed, low micromolar derivative revealed unmet interactions, and suggested the replacement of a lactam carbonyl by an amidine functionality, ultimately leading to a low nanomolar TS inhibitor selected for clinical trials. i36 ... [Pg.624]

Fig. 6. Chemical structures of inhibitors of thymidylate synthase designed based on modifications of 5,10-methylene tetrahydrofolate (a) ZD1694, (b) OSI1843U89. (c) CB3717 (34). Fig. 6. Chemical structures of inhibitors of thymidylate synthase designed based on modifications of 5,10-methylene tetrahydrofolate (a) ZD1694, (b) OSI1843U89. (c) CB3717 (34).
Varney, M.D., Marzoni, G.P., Palmer, C.L., et al. (1992) Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase. J. Med. Chem. 35, 663-676. [Pg.118]

Thymidylate synthase (TS) catalyses the methylation of deoxyuridylate to thymidylate using 5,10-methylenetetra-hydrofolate (Fig. 26.17a) as a coenzyme. TS inhibitors have potential as chemotherapeutic agents for the treatment of cancer as TS provides the sole biosynthetic source of thymidylate, a precursor in DNA biosynthesis. The design of TS inhibitors is a superb example of structure-based dmg design. The reader is urged to read the original papers, which describe the work in great detail. °... [Pg.434]


See other pages where Thymidylate synthase inhibitor design is mentioned: [Pg.14]    [Pg.114]    [Pg.683]    [Pg.326]    [Pg.327]    [Pg.264]    [Pg.285]    [Pg.247]    [Pg.109]    [Pg.210]    [Pg.326]    [Pg.327]    [Pg.1517]    [Pg.426]    [Pg.549]    [Pg.285]    [Pg.632]    [Pg.220]    [Pg.144]    [Pg.215]    [Pg.124]    [Pg.667]    [Pg.65]    [Pg.430]    [Pg.434]    [Pg.327]    [Pg.163]    [Pg.177]    [Pg.109]   
See also in sourсe #XX -- [ Pg.425 , Pg.426 , Pg.427 , Pg.428 ]

See also in sourсe #XX -- [ Pg.425 , Pg.426 , Pg.427 , Pg.428 ]




SEARCH



Inhibitor design

Thymidylate

Thymidylate synthase

Thymidylate synthase inhibitors

© 2024 chempedia.info